Project cooperationUpdated on 18 June 2026
Clinical and research collaborations in addiction treatment
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
About
MFD is seeking clinical and scientific collaborators interested in developing new pharmacological support solutions for behavioural addiction therapies.
The company develops cannabis medicated chewing gums designed to help manage anxiety peaks and craving during treatment. The technology is based on a pharmaceutical-grade, single-dose oral dosage form with controlled delivery through the buccal mucosa.
We are looking to collaborate with hospitals, addiction units, CROs, universities and research groups to explore clinical studies in different addiction-related indications, including Cannabis Use Disorder (CUD), alcohol, cocaine and opioid dependence
Stage
- Planning
Type
- Research
- Financing
Attached files
Organisation
Similar opportunities
Product
Cannabis medicated chewing gums for addiction treatment
- Health innovation
- Distribution Partner
- Pharmaceutical industry
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
Partnership
Pharmaceutical partnerships for innovative addiction medicines
- Others
- Development
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain
Investment
Investment opportunity in cannabis medicines for addiction treatment
- Healthcare
- Seed and Development
David Molinero Caravantes
CEO at MEDICAL FLOWERS DEVELOPMENTS
MADRID, Spain